FTO and acute myeloid leukemia: From the results of an in vitro experiment and a mouse transplantation model, FB23-2, as the inhibitor of FTO, can significantly reduce the proliferation of human AML cell lines and primary AML cells, promote their differentiation and apoptosis, and significantly inhibit the malignant progression of tumors [103,104].